Yale 2014

Trial name or title	Treatment of Hepatic Encephalopathy with Flumazenil and Change in Cortical Gamma Aminobutyric Acid Levels in MRS [magnetic resonance spectroscopy].
Methods	Randomised clinical trial.
Participants	Participants with non‐alcoholic cirrhosis and hepatic encephalopathy.
Interventions	Flumazenil and placebo.
Outcomes	Recovery from hepatic encephalopathy and change in cortical gamma aminobutyric acid levels.
Starting date	November 2014.
Contact information	Deanna Martin, deanna.martin@yale.edu and Amanda Brennan amanda.brennan@yale.edu.
Notes	Estimated completion date: June 2017.